ReviewFrontiers in immunology2026
Transient short-chain fatty acid exposure and the temporal question of epithelial barrier immunity.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies of microbiome-targeted interventions often use persistence of an administered organism or endpoint metabolite abundance as markers of biological consequence, but host barriers may be altered by microbial chemistry after the initiating exposure has disappeared. Short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, provide a tractable model for this temporal problem because they connect microbial fermentation to epithelial metabolism, G protein-coupled receptor signaling, tight-junction regulation, immune tone, and chromatin-associated gene regulation. This Perspective argues that SCFA biology should be used to distinguish three outcomes at the host-microbial interface: exposure-dependent modulation, reversible epithelial reprogramming, and durable barrier imprint. Current evidence supports robust epithelial responses to SCFAs and makes persistence biologically plausible through chromatin-associated regulation and epithelial immune memory, but it does not yet establish whether brief adult SCFA exposure can alter later barrier behavior after withdrawal. Clarifying this conversion step will provide a common temporal framework for dietary, prebiotic, probiotic, postbiotic, and microbiota-transfer studies by distinguishing intervention delivery and engraftment from epithelial persistence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.